MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
Provided By GlobeNewswire
Last update: Oct 10, 2024
Secured additional R&D collaborations with Solventum and Mölnlycke for optimal trial consistency and patient outcomes
Study to support EscharEx® BLA submission and strengthen commercialization strategy
Read more at globenewswire.com
